Drug Type Small molecule drug |
Synonyms NTX 083 |
Target |
Action inhibitors |
Mechanism ATP1A3 inhibitors(Sodium/potassium-transporting ATPase subunit alpha-3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Preclinical | Japan | 15 Jul 2025 |





